SRC and cancer: Claramine did not affect glucose uptake by the GBM cells and had no effect on IRS-1 phosphorylation, suggesting that the anti-tumoral effect of PTP1B inhibition in these cancer cells relies mainly in Src inhibition and not on glucose homeostasis.